Zdrowie i gospodarka · 11/06/2014
FDA Releases Draft Guidance on Distributing Risk Information for Prescription Drugs
The Food and Drug Administration (FDA) has released a draft guidance outlining recommended practices for pharmaceutical companies to share new risk information about approved prescription drugs with healthcare professionals, in an effort to improve transparency and safety.